ON RELATIONSHIP BETWEEN LIPID SOLUBILITY TISSUE BINDING AND METABOLISM OF XANTHINE DERIVATIVES AND THEIR PASSAGE INTO BRAIN AND CEREBROSPINAL FLUID

被引：13

作者：

HESS, R

TESCHEMACHER, HJ

HERZ, A

机构：

来源：

NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE | 1968年 / 261卷 / 05期

关键词：

D O I：

10.1007/BF00537563

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：469 / +

页数：1

共 23 条

[1] AXELROD J, 1953, J PHARMACOL EXP THER, V107, P519
[2] BRODIE BB, 1952, J PHARMACOL EXP THER, V105, P421
[3] BRODIE BB, 1960, J PHARMACOL EXP THER, V130, P20
[4] BRODIE BB, 1952, J BIOL CHEM, V194, P215
[5] BUCHI J, 1963, GRUNDLAGEN ARZNEIMIT
[6] DAVSON H, 1963, BLOODBRAIN BARRIER, V4, P71
[7] BLOOD-BRAIN BARRIER
DOBBING, J
[J]. PHYSIOLOGICAL REVIEWS, 1961, 41 (01) : 130 - +
[8] FIREMARK H, 1963, INT J NEUROPHARMACOL, V2, P25
[9] GOLDSTEIN A, 1960, J PHARMACOL EXP THER, V128, P1
[10] INHIBITION OF DOPAMINE BETA-OXIDASE BY AMPHETAMINE AND P-HYDROXYAMPHETAMINE
GOLDSTEIN, M
[J]. BIOCHEMICAL PHARMACOLOGY, 1961, 8 (01) : 163 - &